Healthcare Analysts provide a quick recap of GA Physician Survey results on an Analyst/Industry conference call to be held on March 18 at 11:30 ...

Lico, President and Chief Executive Officer, and Olumide Soroye, President and Chief Executive Officer of Intelligent Operating Solutions and Advanced Healthcare Solutions, will be presenting at the J ...

Switching to IMVT-1402 extends the head starts Immunovant has already ceded to its rivals. Argenx won FDA approval for ...

At a time when CRISPR companies have struggled, the Feng Zhang spinoff Arbor Biotechnologies gets a cash infusion to head to clinical trials.

Dublin, Feb. 28, 2025 (GLOBE NEWSWIRE) -- The "43rd Annual JP Morgan Healthcare Conference, January 13-16, 2025" report has been added to ResearchAndMarkets.com's offering. The 43rd Annual JP ...

The CARAai platform supports a wide range of enterprise healthcare and life sciences use cases and solutions. Over the course of 2025, ConcertAI will be launching a series of new AI SaaS solutions ...

During the week of the 2025 J.P. Morgan Healthcare Conference in San Francisco, life sciences partners Suzanne Filippi and Laurie Burlingame led ...

Waymo receives approval to map roads around San Francisco International Airport for potential autonomous vehicle services.

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Feb. 28, 2025 (GLOBE NEWSWIRE) -- The "43rd Annual JP Morgan Healthcare Conference, January 13-16, 2025" report has been added to ResearchAndMarkets.com's ...

In this episode of Denatured, BioSpace's Head of Insights Lori Ellis and Miruna Sasu, CEO of COTA, discuss the challenges of ...

Ravi Saraogi [ph], I run the Distressed Analysts Team on J.P. Morgan's Credit Trading Desk ... I know there's seasoned healthcare experts in the room, there's also generalist, maybe just a ...

A phase 3 trial of AstraZeneca’s $800 million rare disease candidate has met its primary endpoint. The update keeps ...